BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12387462)

  • 1. Dose-response analysis of effects of tibolone on climacteric symptoms.
    Landgren MB; Bennink HJ; Helmond FA; Engelen S
    BJOG; 2002 Oct; 109(10):1109-14. PubMed ID: 12387462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB; Helmond FA; Engelen S
    Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    Kroiss R; Fentiman IS; Helmond FA; Rymer J; Foidart JM; Bundred N; Mol-Arts M; Kubista E
    BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
    Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
    Hammar M; Christau S; Nathorst-Böös J; Rud T; Garre K
    Br J Obstet Gynaecol; 1998 Aug; 105(8):904-11. PubMed ID: 9746385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
    Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone vaginal versus per os administration in the management of post-menopausal symptoms.
    Zervoudis S; Iatrakis G; Peitsidis P; Tsikouras P; Galazios G; Liberis V; Navrozoglou I; Ceauşu I; Badiu C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):471-7. PubMed ID: 21491823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.
    Huber J; Palacios S; Berglund L; Hänggi W; Sathanandan SM; Christau S; Helmond F
    BJOG; 2002 Aug; 109(8):886-93. PubMed ID: 12197367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.
    Bai W; Henneicke-von Zepelin HH; Wang S; Zheng S; Liu J; Zhang Z; Geng L; Hu L; Jiao C; Liske E
    Maturitas; 2007 Sep; 58(1):31-41. PubMed ID: 17587516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of tibolone on quality of life in postmenopausal women.
    Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
    Maturitas; 2002 Jan; 41(1):35-43. PubMed ID: 11809341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
    Morais-Socorro M; Cavalcanti MA; Martins R; Neto Francisco P; Rezende A; Azevedo G; Almeida M
    Gynecol Endocrinol; 2012 Jun; 28(6):483-7. PubMed ID: 22132809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.
    Rymer J; Robinson J; Fogelman I
    Climacteric; 2002 Dec; 5(4):390-8. PubMed ID: 12626219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints.
    Egarter C; Huber J; Leikermoser R; Haidbauer R; Pusch H; Fischl F; Putz M
    Maturitas; 1996 Feb; 23(1):55-62. PubMed ID: 8861087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
    Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
    Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.